Pizotifen

DB06153ApprovedSmall molecule

Pizotifen is a serotonin and tryptamine antagonist indicated for migraine prophylaxis. Pizotifen belongs to the class of antamines and is related to cyproheptadine.

Chemical structure of Pizotifen
Mechanism
Curator reviewed · 6 references
Primary indication
Indicated for the prophylactic management of migraines.Curator reviewed · 1 structured indication
Formula / weight
C19H21NS · 295.44 g/mol (avg)
First approval
Canada, 2009
Also known as
Pizotyline
Code names
BC-105
Brand names
  • Sandomigran

Resolves to

Clinical / RWD
Structure
InChIKeyFIADGNVRKBPQEU-UHFFFAOYSA-NSMILESCN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2

What you can answer from here — as of September 23, 2026

15Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,342Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
21Marketed productsAcross 5 countries and 15 labellers
Sign in
1ATC codeIncluding every combination product, plus 30 drug categories
Sign in
30+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pizotifen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account